Gen ฤฐlaรง, Azerbaycan’daki baฤlฤฑ ortaklฤฑฤฤฑ Gen Pharma Caucasus Manufacturing Operations’ฤฑn sermaye artฤฑrฤฑmฤฑna katฤฑldฤฑ. ลirket, %66 hissedarlฤฑk oranฤฑnฤฑ korumak รผzere kendi payฤฑna dรผลen 9,8 milyon dolar (16,6 milyon AZN) tutarฤฑndaki sermaye รถdemesini tamamladฤฑ.
Sermaye artฤฑrฤฑmฤฑ sonrasฤฑnda Gen Pharma Caucasus’un รถdenmiล sermayesi 45,6 milyon AZN (26,8 milyon dolar) tutarฤฑna yรผkseldi. Daha รถnce Mart ayฤฑnda yapฤฑlan sermaye artฤฑrฤฑmฤฑnda ลirketin รถdenmiล sermayesi 20,4 milyon AZN’ye รงฤฑkarฤฑlmฤฑลtฤฑ.
Hissedarlฤฑk yapฤฑsฤฑ deฤiลmeden kaldฤฑ. Gen ฤฐlaรง %66 (30,1 milyon AZN / 17,7 milyon dolar), Azerbaycan ฤฐล Geliลtirme Fonu %29 ve SIA Pharmaceutical %5 oranฤฑnda hisseye sahip.
Gen Pharma Caucasus, Azerbaycan’da ilaรง รผretim tesisi inลa eden ลirket olarak faaliyet gรถsteriyor.
| รzel Durum Aรงฤฑklamasฤฑ (Genel) | |
| Yapฤฑlan Aรงฤฑklama Gรผncelleme mi? | Evet (Yes) |
| Yapฤฑlan Aรงฤฑklama Dรผzeltme mi? | Hayฤฑr (No) |
| Konuya ฤฐliลkin Daha รnce Yapฤฑlan Aรงฤฑklamanฤฑn Tarihi | 03.03.2026 |
| Yapฤฑlan Aรงฤฑklama Ertelenmiล Bir Aรงฤฑklama mฤฑ? | Hayฤฑr (No) |
| Bildirim ฤฐรงeriฤi | |
| Aรงฤฑklamalar | |
03.03.2026 tarihli KAP aรงฤฑklamamฤฑzda, baฤlฤฑ ortaklฤฑฤฤฑmฤฑz Gen Pharma Caucasus Manufacturing Operations MMC ("Gen Pharma Caucasus") ลirketinin sermaye artฤฑrฤฑmฤฑna Gen ฤฐlaรง ve Saฤlฤฑk รrรผnleri Sanayi ve Ticaret A.ล. ("GEN") olarak katฤฑldฤฑฤฤฑmฤฑzฤฑ ve Gen Pharma Caucasus'un รถdenmiล sermayesinin 20.400.000 AZN (12.000.000 USD) tutarฤฑna รงฤฑkarฤฑldฤฑฤฤฑnฤฑ duyurmuลtuk. (https://www.kap.org.tr/tr/Bildirim/1565024) GEN'in %66,00 oranฤฑnda hissedarฤฑ olduฤu ve aynฤฑ zamanda Azerbaycan'da ilaรง รผretim tesisi inลa eden Gen Pharma Caucasus'un รถdenmiล sermayesinin 45.560.000 AZN (26.800.000 USD) tutarฤฑna รงฤฑkarฤฑlmasฤฑ kapsamฤฑnda; sermaye artฤฑrฤฑm sรผrecine dahil olan GEN'in %66,00 olan hissedarlฤฑk oranฤฑ sabit kalmak รผzere, kendi payฤฑna dรผลen 9.768.000 USD (16.605.600 AZN) tutarฤฑndaki sermaye รถdemesi tamamlanmฤฑลtฤฑr. Sermaye artฤฑrฤฑmฤฑ sonrasฤฑnda Gen Pharma Caucasus ลirketinde GEN'in %66,00 (30.069.600,00 AZN / 17.688.000 USD), Azerbaycan ฤฐล Geliลtirme Fonu'nun (ABฤฐF) %29,00 ve SIA Pharmaceutical'ฤฑn %5,00 olan hissedarlฤฑk oranlarฤฑ sabit olarak kalmฤฑลtฤฑr. ฤฐลbu aรงฤฑklamamฤฑzฤฑn ฤฐngilizce รงevirisi ekte yer almakta olup, metinler arasฤฑnda herhangi bir farklฤฑlฤฑk olmasฤฑ durumunda, Tรผrkรงe aรงฤฑklama metni esas kabul edilecektir. -Unofficial Translation- In our Public Disclosure Platform (KAP) announcement dated March 3, 2026, it was announced that Gen ฤฐlaรง ve Saฤlฤฑk รrรผnleri Sanayi ve Ticaret A.ล. ("GEN") participated in the capital increase of its subsidiary, Gen Pharma Caucasus Manufacturing Operations MMC ("Gen Pharma Caucasus"), and that the Company's paid-in capital was increased to AZN 20,400,000.00 (USD 12,000,000.00).(https://www.kap.org.tr/en/Bildirim/1565024) Within the scope of the capital increase of Gen Pharma Caucasus, in which our Company holds a 66.00% stake, to AZN 45,560,000 (USD 26,800,000.00), an totaly additional investment of USD 9,768,000.00 (AZN 16,605,600.00) has been completed by GEN. The shareholding structure of Gen Pharma Caucasus, with GEN holding 66.00% (AZN 30,069,600.00 / USD 17,688,000.00), the Azerbaijan Business Development Fund (ABDF) holding 29.00%, and SIA Pharmaceutical holding 5.00%, has remained unchanged upon completion of the capital increase process. In case of any discrepancy between the Turkish and English texts, the Turkish text shall prevail. | |







